PROCEPT BioRobotics Corp
Closed
SectorHealthcare
25.8 -6.66
Overview
Share price change
24h
Min
25.19
Max
25.95
Income | -1.8M -32M |
|---|---|
Sales | 6.7M 83M |
EPS | -0.56 |
Profit margin | -38.058 |
Employees | 888 |
EBITDA | -9.1M -31M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +16.73% upside |
Next Earnings | 5 sie 2026 |
|---|
Market Cap | 250M 1.6B |
|---|---|
Previous open | 32.46 |
Previous close | 25.8 |
PROCEPT BioRobotics Corp Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
PROCEPT BioRobotics Corp Forecast
Price Target
By TipRanks
16.73% upside
12 Months Forecast
Average 30 USD 16.73%
High 35 USD
Low 20 USD
Based on 9 Wall Street analysts offering 12 month price targets forPROCEPT BioRobotics Corp - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About PROCEPT BioRobotics Corp
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.